Inflammatory bowel disease: treatment and management
You must score at least 70% in this module to pass. Ensure you have read ‘Inflammatory bowel disease: treatment and management’ before attempting to complete the module.
This module can be taken up to three times. Once you have passed, you can view the correct answers and download a certificate as a record of your learning.
Additional CPD modules are available in the ‘My CPD’ section of your account.
Quiz Summary
0 of 15 Questions completed
Questions:
Information
You have already completed the quiz before. Hence you can not start it again.
Quiz is loading…
You must sign in or sign up to start the quiz.
You must first complete the following:
Results
Results
0 of 15 Questions answered correctly
Your time:
Time has elapsed
You have reached 0 of 0 point(s), (0)
Earned Point(s): 0 of 0, (0)
0 Essay(s) Pending (Possible Point(s): 0)
Categories
- Not categorized 0%
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- Current
- Review
- Answered
- Correct
- Incorrect
- Question 1 of 15
1. Question
What percentage of inflammatory bowel disease teams in the UK meet the standards for pharmacist involvement?
CorrectIncorrect - Question 2 of 15
2. Question
In treatment for inflammatory bowel disease, ‘conventional therapy’ refers to which agents?
CorrectIncorrect - Question 3 of 15
3. Question
Which of the statements regarding 5-ASA is true?
CorrectIncorrect - Question 4 of 15
4. Question
What is recommended for patients who are refractory to 5-ASA and require stepping up to steroids?
CorrectIncorrect - Question 5 of 15
5. Question
Budesonide and beclomethasone are which generation of corticosteroids?
CorrectIncorrect - Question 6 of 15
6. Question
Which metabolite of mercaptopurine should be monitored following commencement of a thiopurine?
CorrectIncorrect - Question 7 of 15
7. Question
Allopurinol is a xanthine oxidase inhibitor which prevents the breakdown of thiopurines to thiouric acid. What dose of allopurinol should be used in combination with low dose thiopurine to correct hypermethylation?
CorrectIncorrect - Question 8 of 15
8. Question
Which anti-TNFs are licensed for both ulcerative colitis and Crohn’s disease?
CorrectIncorrect - Question 9 of 15
9. Question
Combination anti-TNF and thiopurine therapy increases the risk of serious opportunistic infections. Prophylaxis with which agent should be considered?
CorrectIncorrect - Question 10 of 15
10. Question
Which interleukins are inhibited by ustekinumab?
CorrectIncorrect - Question 11 of 15
11. Question
Which of the following criteria is not a red flag when initiating tofacitinib?
CorrectIncorrect - Question 12 of 15
12. Question
Which of the following drugs is not available as an intravenous/subcutaneous formulation?
CorrectIncorrect - Question 13 of 15
13. Question
Patients taking vedolizumab should be counselled to look out for symptoms of which neurological disorder?
CorrectIncorrect - Question 14 of 15
14. Question
Nutrient deficiencies are common in inflammatory bowel disease. Which micronutrients should be monitored and replaced?
CorrectIncorrect - Question 15 of 15
15. Question
Patients receiving immunosuppressive drugs should avoid receiving live vaccines (e.g. the BCG vaccine) for how long after terminating treatment?
CorrectIncorrect